We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 26 start-ups with an aggregate funding of $830.4m. The average funding per company in this subset is $31.9m.
Last update to the database: Feb 18, 2025. See changelog.
6
Funding Rounds
$230.6m
Money raised
Leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
1
Funding Rounds
$16.0m
Money raised
A pharmaceutical company that develops topical products to treat rare diseases
5
Funding Rounds
$10.4m
Money raised
mediQuo is changing the way patients interact with health professionals, improving their lives.
1
Funding Rounds
$8.1m
Money raised
Accure Therapeutics is a neuro Treatments founded in 2020.
13
Funding Rounds
$147.7m
Money raised
Minoryx Therapeutics is a small Molecules for Rare Diseases founded in 2011.
5
Funding Rounds
$113.1m
Money raised
Provider of AI-driven computational biology solutions for the early detection of cancer.
6
Funding Rounds
$40.7m
Money raised
Oryzon Genomics is a clinical stage biopharmaceutical company.
5
Funding Rounds
$7.6m
Money raised
A personalized medicine company focused on the development of biomarkers to predict bone metastasis in cancers
2
Funding Rounds
$3.2m
Money raised
Online platform for identifying, interacting, and booking e-consultations with medical specialists in private healthcare.
2
Funding Rounds
$60.6m
Money raised
A company developing implantable devices to treat inflammatory diseases
2
Funding Rounds
$5.7m
Money raised
Developer of a neural network system intended to connect pharmacy and patient. The company's system is integrated with pharmacy management tools which interrelates between laboratories, pharmacies, and end customers, enabling customers to locate medicines and reduce shortages.
2
Funding Rounds
$456.2k
Money raised
ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
2
Funding Rounds
$50.9m
Money raised
Clinical stage treatment for Myotonic Dystrophy Type 1
2
Funding Rounds
$21.3m
Money raised
Developer of ADCs to treat metastatic solid tumors.
1
Funding Rounds
Service that focuses on repurposing drugs to treat rare neurological diseases.
1
Funding Rounds
$3.3m
Money raised
Devicare has developed Lit-Control - the most advanced, comprehensive and effective medical treatment for Kidney Stones.
2
Funding Rounds
$2.0m
Money raised
Sagetis Biotech is a company that is committed to developing an innovative polymeric technology
1
Funding Rounds
$2.7m
Money raised
Amadix is a Valladolid-based biotechnology company developing diagnostic tools for oncology treatment.
3
Funding Rounds
$69.5m
Money raised
Ona Therapeutics is a therapeutic biologics platform to treat metastatic cancer founded in 2019.
2
Funding Rounds
$2.9m
Money raised
Nanoligent is a Protein-Nanoparticle Conjugate founded in 2017.
2
Funding Rounds
$4.8m
Money raised
3P Biopharmaceuticals is a manufacturing & Services founded in 2006.
1
Funding Rounds
$1.4m
Money raised
Libera Bio is an addressing "undruggable intracellular targets" in oncology founded in 2020.
1
Funding Rounds
StablevaX™ platform provider for fridge-free vaccine and pharmaceutical products.
1
Funding Rounds
$1.2m
Money raised
Mikrobiomik is a drug developer for chronic diseases founded in 2018.
1
Funding Rounds
$26.1m
Money raised
Grupo IMO is a Madrid-based company.
Enter your email and get access to 71,000 + technology companies you can partner with.